Overview

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design

Status:
COMPLETED
Trial end date:
2017-11-14
Target enrollment:
Participant gender:
Summary
A 21-Day, Randomized, Controlled Study to Evaluate the Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design To evaluate the irritation potential of MOB015B on normal skin. Single center, randomized, controlled, evaluator blinded, within-subject comparison study
Phase:
PHASE1
Details
Lead Sponsor:
Moberg Pharma AB
Treatments:
long-chain-aldehyde dehydrogenase
Saline Solution